Assessment of the Fungal Infection Incidence Across Canada for High Risk Participants With Hematological Disease (P07501)
- Status
- COMPLETED
- Phase
- N/A
Clinical Trials Related to Merck Sharp & Dohme LLC
Related studies linked through entity extraction aliases.
REVEAL: Randomized EValuation of the Effects of Anacetrapib Through Lipid-modification
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Treat Stroke to Target
- Status
- COMPLETED
- Phase
- NA
The Effect of Pregnancy on the PK of Isentress®: A Longitudinal Investigation in the Second and Third Trimesters
- Status
- WITHDRAWN
- Phase
- N/A
Hepatitis B Challenge Dose in Adults (V232-059-10)
- Status
- COMPLETED
- Phase
- PHASE3
MK-2206 for Recurrent Malignant Glioma
- Status
- WITHDRAWN
- Phase
- PHASE2
BATTLE-2 Program: A Biomarker-Integrated Targeted Therapy Study in Previously Treated Patients With Advanced Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
The Influence of GINkGo Biloba on the Pharmacokinetics of the UGT Substrate raltEgraviR (GINGER)
- Status
- COMPLETED
- Phase
- PHASE1
Efficacy Study of Pre-emptive Etoricoxib for Postoperative Pain and Functional Outcome in Total Knee Arthroplasty
- Status
- COMPLETED
- Phase
- PHASE2
GARDASIL™ Study in Healthy Females Between 9 and 26 Years of Age in Sub-Saharan Africa (V501-046)
- Status
- COMPLETED
- Phase
- PHASE3
Safety, Tolerability, and Immunogenicity of a Booster Dose of Zoster Vaccine, Live (V211-029)
- Status
- COMPLETED
- Phase
- PHASE3
Effect of Statins on Lipid Levels Following the First Acute Coronary Event (MK-0000-204)
- Status
- COMPLETED
- Phase
- N/A
Addition of Raltegravir to Established Antiretroviral Suppressive Therapy
- Status
- TERMINATED
- Phase
- PHASE4
A Study of Two Methodologies for Measuring Blood Flow in the Brain in Response to Non-Drug Stimuli (P08085/MK-0000-180)
- Status
- COMPLETED
- Phase
- PHASE1
Safety, Pharmacodynamics, and Pharmacokinetics of Different Dosing Regimens of MK-8266 in Participants With Hypertension (MK-8266-008)
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Dalotuzumab + MK-2206, Dalotuzumab + MK-0752, and Dalotuzumab + Ridaforolimus Combination Therapies in Participants With Advanced Cancer (MK-0646-027)
- Status
- TERMINATED
- Phase
- PHASE1
A Study of MK-3415, MK-6072, and MK-3415A in Participants Receiving Antibiotic Therapy for Clostridium Difficile Infection (MK-3415A-001)
- Status
- COMPLETED
- Phase
- PHASE3
Prospective Population Study on Candidemia in Spain
- Status
- COMPLETED
- Phase
- N/A
MK-2206, Paclitaxel and Trastuzumab in Treating Patients With HER2-overexpressing Solid Tumor Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Evaluate and Compare the Efficacy and Pharmacokinetics of MK-0873 for the Treatment of Plaque Psoriasis (MK-0873-022)
- Status
- COMPLETED
- Phase
- PHASE1